Inventor · disambiguated record
Stuart A. Lipton
Also filed as: LIPTON STUART · LIPTON STUART A · LIPTON STUART ARTHUR
27 granted patents·24 pending applications·827 citations·filing 1980–2023
97Inventor score
Files withLIPTON STUART A12CHILDRENS MEDICAL CENTER11BURNHAM INST MEDICAL RESEARCH4ADAMAS PHARMACEUTICALS INC2NEUROMOLECULAR INC2
Top patents by PatentIndex Score
51 records- 0195US5922773AGlaucoma treatmentCHILDRENS MEDICAL CENTER·Filed 1992·Granted Jul 13, 1999·173 cites·16 claims
- 0294US6444702B1Aminoadamantane derivatives as therapeutic agentsNEUROMOLECULAR INC·Filed 2000·Granted Sep 3, 2002·68 cites·25 claims
- 0393US5614560AMethod of preventing NMDA receptor-mediated neuronal damageCHILDRENS MEDICAL CENTER·Filed 1995·Granted Mar 25, 1997·133 cites·19 claims
- 0491US5334618AMethod of preventing NMDA receptor-mediated neuronal damageCHILDRENS MEDICAL CENTER·Filed 1992·Granted Aug 2, 1994·93 cites·14 claims
- 0590US6620845B2Aminoadamantane derivatives as therapeutic agentsNEUROMOLECULAR INC·Filed 2002·Granted Sep 16, 2003·38 cites·4 claims
- 0687US11529319B2Methods and compositions for treating neurological conditionsLIPTON STUART A·Filed 2018·Granted Dec 20, 2022·2 cites·15 claims
- 0786US7326730B2Aminoadamantane derivatives as therapeutic agentsADAMAS PHARMACEUTICALS INC·Filed 2005·Granted Feb 5, 2008·7 cites·13 claims
- 0884US6482854B1Glaucoma treatmentMASSACHUSETTS EYE & EAR INFIRM·Filed 1999·Granted Nov 19, 2002·73 cites·9 claims
- 0979US8022246B2Neuroprotective compositions and methodsBURNHAM INST MEDICAL RESEARCH·Filed 2007·Granted Sep 20, 2011·4 cites·11 claims
- 1079US7439063B2Neuroprotective synergy of erythropoietin and insulin-like growth factorsBURNHAM INST MEDICAL RESEARCH·Filed 2003·Granted Oct 21, 2008·19 cites·68 claims
- 1178US5506231ATreatment of aids dementia, myelopathy and blindnessCHILDRENS MEDICAL CENTER·Filed 1993·Granted Apr 9, 1996·53 cites·17 claims
- 1278US5234956AMethod of preventing NMDA receptor complex-mediated neuronal damageCHILDRENS MEDICAL CENTER·Filed 1992·Granted Aug 10, 1993·35 cites·13 claims
- 1375US12071392B2Aminoadamantyl nitrate compounds and their use to treat CNS disordersPANORAMA RES INC·Filed 2022·Granted Aug 27, 2024·0 cites·17 claims
- 1473US8236563B2Methods of differentiating and protecting cells by modulating the p38/MEF2 pathwayLIPTON STUART A·Filed 2011·Granted Aug 7, 2012·2 cites·20 claims
- 1572US5455279ARegimen method of mediating neuronal damage using nitroglycerineCHILDRENS MEDICAL CENTER·Filed 1993·Granted Oct 3, 1995·32 cites·11 claims
- 1671US2010137448A1Methods for Treating Neuropsychiatric Disorders with NMDA Receptor AntagonistsLIPTON STUART A·Filed 2009·Application pending·0 cites
- 1769US2009234021A1Treatment of Demyelinating ConditionsLIPTON STUART A·Filed 2008·Application pending·0 cites
- 1865US2025161243A1Mef2 transcriptional activators to treat neurologic conditionsSCRIPPS RESEARCH INST·Filed 2023·Application pending·0 cites
- 1964US7919317B2Methods of differentiating and protecting cells by modulating the P38/MEF2 pathwaySANFORD BURNHAM MED RES INST·Filed 2001·Granted Apr 5, 2011·1 cites·20 claims
- 2064US7790404B2Excitatory glycine receptors and methodsSANFORD BURNHAM MEDICAL RES IN·Filed 2002·Granted Sep 7, 2010·1 cites·20 claims
- 2163US2008183003A1Aminoadamantane derivatives as therapeutic agentsADAMAS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2262US6503947B1Method of treating cytotoxic damageBRIGHAM & WOMENS HOSPITAL·Filed 1999·Granted Jan 7, 2003·29 cites·55 claims
- 2362US5053419ATreatment of AIDS dementia, myelopathy and blindnessCHILDRENS MEDICAL CENTER·Filed 1990·Granted Oct 1, 1991·16 cites·10 claims
- 2462US2025122146A1Compounds for reducing neuroinflammationSCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
- 2561US5801203ANitroglycerine patchCHILDRENS MEDICAL CENTER·Filed 1995·Granted Sep 1, 1998·17 cites·1 claims
- 2661US2005065219A1Treatment of demyelinating conditionsFiled 2004·Application pending·0 cites
- 2759US5747545AMethod of preventing NMDA receptor complex-mediated Neuronal damageCHILDRENS MEDICAL CENTER·Filed 1995·Granted May 5, 1998·16 cites·1 claims
- 2856US2005124701A1Method of targeting a therapeutic agentFiled 2004·Application pending·0 cites
- 2956US2007218121A1Compounds that inhibit caspase activity for treating glaucomaLIPTON STUART A·Filed 2006·Application pending·0 cites
- 3055US2004265369A1Compounds that inhibit caspase activity for treating glaucomaFiled 2004·Application pending·0 cites
- 3155US2004029929A1Aminoadamantane derivatives as therapeutic agentsFiled 2003·Application pending·0 cites
- 3254US2023218548A1Nitro-aminoadamantane compounds for the treatment of betacoronavirus infectionsEUMENTIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3352US2009093409A1Neuroprotective synergy of erythropoietin and insulin-like growth factorsBURNHAM INST MEDICAL RESEARCH·Filed 2008·Application pending·0 cites
- 3450US2002106404A1Compounds that inhibit caspase activity for treating glaucomaFiled 2002·Application pending·0 cites
- 3549US8193315B2Excitatory glycine receptors and methodsLIPTON STUART A·Filed 2010·Granted Jun 5, 2012·0 cites·7 claims
- 3649US2009088367A1Treatment of Insulin Resistance/Metabolic Syndrome to Alleviate the Risks of DementiaBURNHAM INST MEDICAL RESEARCH·Filed 2005·Application pending·0 cites
- 3748US2003100482A1NMDA oxidizing agents for protecting neurons from injuryCHILDREN S MEDICAL CT CORP INC·Filed 2003·Application pending·0 cites
- 3846US8466311B2Neuroprotective compositions and methodsLIPTON STUART A·Filed 2011·Granted Jun 18, 2013·0 cites·3 claims
- 3946US2004122090A1Methods for treating neuropsychiatric disorders with nmda receptor antagonistsFiled 2001·Application pending·0 cites
- 4045US2007292400A1Media conditioned by human embryonic stem cells or other progenitor cells and uses thereforLIPTON STUART A·Filed 2007·Application pending·0 cites
- 4145US2011293556A1Treatment of insulin resistance/metabolic syndrome to alleviate the risks of dementiaLIPTON STUART A·Filed 2011·Application pending·0 cites
- 4244US6071876AMethod of preventing NMDA receptor complex-mediated neuronal damageCHILDRENS MEDICAL CENTER·Filed 1998·Granted Jun 6, 2000·7 cites·5 claims
- 4342US2011091568A1Media conditioned by stem cells and uses thereforLIPTON STUART A·Filed 2010·Application pending·0 cites
- 4441US2003078274A1Method of reducing neuronal injury or apoptosisFiled 2002·Application pending·0 cites
- 4540US2009209615A1Inhibitors of matrix metalloproteinases to treat neurological disordersLIPTON STUART·Filed 2005·Application pending·0 cites
- 4638US2003092004A1Excitatory glycine receptors and methodsFiled 2001·Application pending·0 cites
- 4738US2005004022A1Pharmaceutical compositions for treating painful neuropathy and methods of treating sameFiled 2004·Application pending·0 cites
- 4838US2011171291A1Pathologically-activated therapeuticsSANFORD BURNHAM MED RES INST·Filed 2011·Application pending·0 cites
- 4935US6525017B1Using glutathiane to protect neurons from injuryCHILDRENS MEDICAL CENTER·Filed 1994·Granted Feb 25, 2003·4 cites·4 claims
- 5029US7091329B1Protein 68075 and its use for regenerating nerve cell processesLIPTON STUART A·Filed 1994·Granted Aug 15, 2006·0 cites·4 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stuart A. Lipton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →